Jessica Hagen
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.
Dr. Guido Giunti highlights his upcoming HIMSS26 talk that will encourage attendees to ask sharper questions about AI and feel empowered to drive change at any level of healthcare.
The company has filed to list its Class A shares as it looks to scale its AI- and blockchain-enabled telehealth platform after U.S. expansion and private financing.
Emerging Technologies
Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.
The company was granted a preliminary injunction blocking U.S. sales of an alleged copycat fitness tracker by Chinese company Shenzhen Lexqi Electronic Technology Co.
The round brings the AI-enabled text-to-speech company's total funding to $781 million.
Dr. Jacqueline Naeem of Parkland Center for Clinical Innovation previews her upcoming HIMSS26 talk on how health systems can use EHR data to protect frontline staff.
The company will use the funding for research and development, to launch new agentic AI tools across multiple modalities, and to scale its engineering, product and growth teams.
Emerging Technologies
Alex Richter of SciTech Innovation Hub, which won the World Economic Forum’s 2025 Public-Private Collaboration Award, joined MobiHealthNews to discuss emerging technologies.